You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆大健康(00708.HK)料恆馳量產後有助扭虧
阿思達克 03-30 17:43
恆大健康(00708.HK)去年全年虧損擴大至44.26億元人民幣,對比2018年同期蝕14.29億元人民幣。被問到何時扭虧,首席財務官潘大榮表示,新能源汽車產業鏈及回報周期較長,現階段為投入期,虧損主要是由於近年的前期股權投資、工廠建設及技術研發投入所致,預期旗下新能源汽車恆馳於2021至2022年量產後,投入將逐步會減少,屆時財務表現將有所改善。他強調,公司背靠母企恆大(03333.HK)資金及規模支持,未感擔憂。

集團計劃研發研發14款新車型,問及疫情對研發及生產進度的影響,董事長時守明表示,分布各國工程師及設計師都在如期推進計劃,又透露今年將完成部分車款的樣車優先設置,預期自家車型恆馳1將於今年推出,全系列產品明年起陸續實現全面量產。

潘大榮補充,廣東、上海、天津、遼寧等多個整車生產基地都正建設中,料首期合計提供總產能逾100萬輛,當中廣東南沙及上海松江工廠預期今年下半年竣工,明年可投產,首期規模產能均20萬輛。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account